Phase 2 Acute Lymphoblastic Leukemia, Pediatric Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Acute Lymphoblastic Leukemia, Pediatric
Hyoung Jin Kang74 enrolled6 locationsNCT06257394
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University170 enrolled1 locationNCT06564493
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL
Acute Lymphoblastic Leukemia, Pediatric
The First Affiliated Hospital of Zhengzhou University276 enrolled1 locationNCT06559345
Recruiting
Phase 1Phase 2
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504